myCAFs have elevated expression of αSMA, are closely adjacent to tumor cells, and are associated with ECM deposition (35, 37, 38), immunosuppression (39, 40), and tumor restraint (34, 35). The gene discussed is ACTA1; the disease is neoplasm.